BLFS
Price
$37.10
Change
+$0.13 (+0.35%)
Updated
Aug 21 closing price
Capitalization
1.81B
74 days until earnings call
Intraday BUY SELL Signals
QUCY
Price
$1.30
Change
-$0.06 (-4.41%)
Updated
Aug 21 closing price
Capitalization
109.29M
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLFS vs QUCY

BLFS vs QUCY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BLFS vs. QUCY commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and QUCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (BLFS: $37.10 vs. QUCY: $1.30)
Brand notoriety: BLFS and QUCY are both not notable
BLFS represents the Pharmaceuticals: Other, while QUCY is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 56% vs. QUCY: 30%
Market capitalization -- BLFS: $1.81B vs. QUCY: $109.29M
BLFS [@Pharmaceuticals: Other] is valued at $1.81B. QUCY’s [@Medical Specialties] market capitalization is $109.29M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $133.83B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.59B. The average market capitalization across the [@Medical Specialties] industry is $18.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 0 FA rating(s) are green whileQUCY’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 0 green, 5 red.
  • QUCY’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than QUCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 2 TA indicator(s) are bullish while QUCY’s TA Score has 3 bullish TA indicator(s).

  • BLFS’s TA Score: 2 bullish, 4 bearish.
  • QUCY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than QUCY.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а +5.79% price change this week, while QUCY (@Medical Specialties) price change was -11.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.08%. For the same industry, the average monthly price growth was +10.50%, and the average quarterly price growth was +5.94%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.67%. For the same industry, the average monthly price growth was +14.62%, and the average quarterly price growth was +35.84%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 05, 2026.

QUCY is expected to report earnings on Sep 09, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-0.08% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+5.67% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.81B) has a higher market cap than QUCY($109M). BLFS YTD gains are higher at: 53.433 vs. QUCY (16.071). BLFS has higher annual earnings (EBITDA): -12.07M vs. QUCY (-15.06M). BLFS has more cash in the bank: 81M vs. QUCY (4.45M). QUCY has less debt than BLFS: QUCY (127K) vs BLFS (14.9M). BLFS has higher revenues than QUCY: BLFS (102M) vs QUCY (537K).
BLFSQUCYBLFS / QUCY
Capitalization1.81B109M1,664%
EBITDA-12.07M-15.06M80%
Gain YTD53.43316.071332%
P/E Ratio37.10N/A-
Revenue102M537K18,994%
Total Cash81M4.45M1,820%
Total Debt14.9M127K11,732%
FUNDAMENTALS RATINGS
BLFS: Fundamental Ratings
BLFS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLFSQUCY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 28 days ago
84%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signal:
Gain/Loss:
QUCY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BUG40.650.52
+1.30%
Global X Cybersecurity ETF
XSHQ48.760.41
+0.84%
Invesco S&P SmallCap Quality ETF
AIMS28.390.23
+0.83%
Acuitas Small Cap Active ETF
DEFR26.650.01
+0.03%
Aptus Deferred Income ETF
BOEU32.05-0.33
-1.02%
Direxion Daily BA Bull 2X Shares

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+0.35%
RGEN - BLFS
55%
Loosely correlated
+0.47%
RVTY - BLFS
51%
Loosely correlated
+0.50%
A - BLFS
50%
Loosely correlated
+1.73%
XRAY - BLFS
48%
Loosely correlated
+1.30%
DHR - BLFS
47%
Loosely correlated
+1.36%
More

QUCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, QUCY has been loosely correlated with ACRS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if QUCY jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QUCY
1D Price
Change %
QUCY100%
-4.41%
ACRS - QUCY
41%
Loosely correlated
+1.26%
STXS - QUCY
27%
Poorly correlated
-1.39%
ILMN - QUCY
25%
Poorly correlated
+2.89%
GH - QUCY
24%
Poorly correlated
+1.67%
BLFS - QUCY
23%
Poorly correlated
+0.35%
More